The once-a-day semaglutide pill is approved for reducing the risk of heart disease and Type 2 diabetes, the company said in a ...

We talked to experts in obesity, tobacco, artificial intelligence, HIV, TB and the NHI to find out what we can expect — and ...

How to lose weight in 2026 with the new Wegovy pill. Also in this month’s Your Health column: Is the super flu a real thing; ...

Explore the most influential drug approvals of 2025, highlighting FDA-cleared therapies that impact public health and clinical care.

United States ranked well below nine other thriving countries by a large margin (per The Commonwealth Fund) in health ...

In this week’s edition of InnovationRx, we look at a former Wall Street analyst’s $4 billion obesity drug company, the first ...

When a staggeringly slender Emily Atack posted pictures of her family's Christmas, the last thing she would have expected ...

Online pharmacy platform SaveRxCanada.to said on Wednesday it has begun offering Novo Nordisk's blockbuster diabetes drug, ...

The phenomenon, a symptom of GLP-1 use, may not be a source of concern for most people. But for stars who are often in the ...

Ozempic may be more expensive and harder to find now that compounded semaglutide isn’t available. Here are seven reputable ...

The success of GLP-1 medications has made drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) seem like a magic bullet for weight loss. But using these drugs doesn't mean you ...